Upvote
Downvote
VP of Business Segment, IMMULITE, Plasma Proteins, And Syva
Share Job
- Suggest Revision
$232,000 - $319,000 a year
Full-time
- Vice President of Business Segment, IMMULITE®, Plasma Proteins, and Syva® (IPS)
- Our portfolio, spanning from in-vitro and in-vivo diagnostics to image-guided therapy and innovative cancer care, is crucial for clinical decision-making and treatment pathways.
- The Vice President of Business Segment, IMMULITE®, Plasma Proteins, and Syva® (IPS) will lead a ~$500MM business segment with a team of 15+ marketing and product management professionals with full responsibility for the “upstream” and “downstream” marketing (end to end marketing), product communications, product launch and messaging as well as managing the IPS product portfolio across the global segmented into 8 zones: NAM, LAM, SWE, NWE, CEEC, CHN, APJ, JPN (8 zone business leaders).
- The VP Business Segment IPS will have a seat on the Specialty Lab Solutions (SLS) Business Line (BL) Leadership Team and work closely with peers in R&D, Finance, RA/QA, Clinical Sales, and Supply Chain Management and collaborate across the other peer franchise groups.
- Accountable for sustaining and maximizing market share and profitable growth in markets against competitors with specialized and/or selective offerings, typically add-on core-lab suppliers (Thermo Fisher: therein Phadia and The Binding Site, etc.)
Active Job
Updated 25 days agoSimilar Job
Relevance
Active